249 related articles for article (PubMed ID: 11024171)
1. Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation.
Chang LK; Liu ST
Nucleic Acids Res; 2000 Oct; 28(20):3918-25. PubMed ID: 11024171
[TBL] [Abstract][Full Text] [Related]
2. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
Countryman JK; Gradoville L; Miller G
J Virol; 2008 May; 82(10):4706-19. PubMed ID: 18337569
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of Epstein-Barr virus BRLF1 by USF1 and Rta.
Hung CC; Kuo CW; Wang WH; Chang TH; Chang PJ; Chang LK; Liu ST
J Gen Virol; 2015 Sep; 96(9):2855-2866. PubMed ID: 26297580
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
5. Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta.
Liu P; Speck SH
Virology; 2003 Jun; 310(2):199-206. PubMed ID: 12781707
[TBL] [Abstract][Full Text] [Related]
6. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
7. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
Adamson AL; Kenney SC
Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
[TBL] [Abstract][Full Text] [Related]
8. Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
Francis A; Ragoczy T; Gradoville L; Heston L; El-Guindy A; Endo Y; Miller G
J Virol; 1999 Jun; 73(6):4543-51. PubMed ID: 10233912
[TBL] [Abstract][Full Text] [Related]
9. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
Jung YJ; Choi H; Kim H; Lee SK
J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
[TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.
Ragoczy T; Heston L; Miller G
J Virol; 1998 Oct; 72(10):7978-84. PubMed ID: 9733836
[TBL] [Abstract][Full Text] [Related]
12. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.
Robinson AR; Kwek SS; Hagemeier SR; Wille CK; Kenney SC
J Virol; 2011 Sep; 85(17):8940-53. PubMed ID: 21697476
[TBL] [Abstract][Full Text] [Related]
13. The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation.
Deng Z; Chen CJ; Chamberlin M; Lu F; Blobel GA; Speicher D; Cirillo LA; Zaret KS; Lieberman PM
Mol Cell Biol; 2003 Apr; 23(8):2633-44. PubMed ID: 12665567
[TBL] [Abstract][Full Text] [Related]
14. Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virus.
Chang PJ; Chang YS; Liu ST
J Virol; 1998 Jun; 72(6):5128-36. PubMed ID: 9573284
[TBL] [Abstract][Full Text] [Related]
15. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
J Virol; 2017 May; 91(9):. PubMed ID: 28228591
[TBL] [Abstract][Full Text] [Related]
16. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
Li L; Su X; Choi GC; Cao Y; Ambinder RF; Tao Q
BMC Cancer; 2012 Mar; 12():125. PubMed ID: 22458933
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
18. Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.
Ragoczy T; Miller G
J Virol; 2001 Jun; 75(11):5240-51. PubMed ID: 11333906
[TBL] [Abstract][Full Text] [Related]
19. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.
Zalani S; Holley-Guthrie E; Kenney S
J Virol; 1995 Jun; 69(6):3816-23. PubMed ID: 7745729
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
Adamson AL; Darr D; Holley-Guthrie E; Johnson RA; Mauser A; Swenson J; Kenney S
J Virol; 2000 Feb; 74(3):1224-33. PubMed ID: 10627532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]